Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280
| Autor: | Donna B. Ryan, Tonya D Riddlesworth, William T. Cefalu, George Grunberger, Kelly L. Close, Grazia Aleppo, Roy W. Beck, Aaron J. Kowalski, Adam S. Brown, Richard M. Bergenstal, David B. Sacks, Lutz Heinemann |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Blood Glucose
medicine.medical_specialty Endocrinology Diabetes and Metabolism MEDLINE 030209 endocrinology & metabolism 03 medical and health sciences 0302 clinical medicine Diabetes management Diabetes mellitus Blood Glucose Self-Monitoring Internal Medicine medicine Humans Hypoglycemic Agents 030212 general & internal medicine Intensive care medicine Advanced and Specialized Nursing Glycated Hemoglobin business.industry Continuous glucose monitoring medicine.disease 3. Good health Term (time) Glucose management Diabetes Mellitus Type 1 Glucose Metric (unit) business |
| Zdroj: | Diabetes care. 42(2) |
| ISSN: | 1935-5548 |
| Popis: | We thank Pluchino et al. (1) from the U.S. Food and Drug Administration (FDA) Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, for their thoughtful and detailed commentary. They conclude that our proposed continuous glucose monitoring (CGM)–derived measure called glucose management indicator (GMI) (2) is appropriate for inclusion in CGM software to generate a metric conveying extended glucose exposure that may also prove to be a helpful additional tool to personalize diabetes management. In our estimation, this example of Dr. Lias and her colleagues from the FDA being willing to engage in a dialogue with the authors and the diabetes community focused on finding a solution to a clinical and regulatory quandary (in this case, the use of the potentially confusing term estimated A1C) is worthy of highlighting as a model for future productive … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|